Skip to content

Efficacy of Balance Training and Assessment Systems on Motor Function in Parkinson’s Disease

Efficacy of Balance Training and Assessment Systems on Motor Function in Parkinson’s Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117696
Enrollment
Unknown
Registered
2026-01-27
Start date
2026-01-30
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson’s disease

Interventions

Combined Training Group:Conventional Rehabilitation + Balance Device Training with Foam Pad
Control Group:Conventional Rehabilitation
Device Training Group:Conventional Rehabilitation + Balance Device Training

Sponsors

Shanghai Yangzhi rehabilitation hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Met the 2015 revised diagnostic criteria for primary Parkinson’s disease established by the Movement Disorder Society (MDS); 2.patients with Parkinson’s disease presenting with balance impairment and a Hoehn–Yahr stage>= 2.5; 3.aged 40–90 years, with no restriction on sex; 4.receiving anti-Parkinsonian medication at a stable dosage for at least 3 months prior to enrollment and with no planned medication adjustments over the subsequent 3 months; 5.and voluntarily participated in the study with written informed consent provided.

Exclusion criteria

Exclusion criteria: 1.Patients with active depression or psychosis and/or receiving antidepressant or antipsychotic treatment; 2.those with a history of substance abuse or alcohol dependence; 3.patients with severe cognitive impairment that precluded participation in training; 4.those with severe visual impairment or inner ear or vestibular system disorders; 5.and patients who were currently participating in other clinical studies or had participated in another clinical study or treatment program within the preceding 30 days.

Design outcomes

Primary

MeasureTime frame
Berg Balance Scale (BBS) Score;

Secondary

MeasureTime frame
Functional Magnetic Resonance Imaging (fMRI);Modified Barthel Index (MBI);Montreal Cognitive Assessment (MoCA) Score;Isokinetic Dynamometry Test;Movement Disorder Society-Unified Parkinson's Disease Rating Scale Part III (MDS-UPDRS Part III) Score;Three-Dimensional Gait Analysis (3DGA);Timed Up and Go Test (TUG);39-item Parkinson's Disease Questionnaire (PDQ-39) Summary Index;Freezing of Gait Questionnaire (FOGQ) Total Score;10-Meter Walk Test (10MWT) Gait Speed;Composite Activities-specific Risk of Falls Scale;Sensory Organization Test (SOT) and Limits of Stability (LOS) assessed by Balance Master;Six-Minute Walk Test (6MWT) Distance;

Countries

China

Contacts

Public ContactQing Zhao

Shanghai Yangzhi rehabilitation hospital

qingzhao2010@hotmail.com+86 21 3773 0011

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026